French enforcer agrees to minority stake divestment in medical lab deal

France’s Competition Authority has conditionally approved medical lab operator Inovie's purchase of a rival, in a decision that marks the first time it has found that a buyer’s acquisition of majority and minority stakes in two separate companies will harm competition.

Get unlimited access to all Global Competition Review content